Answers are grounded in this paper and cite their sources.
PCR analysis improves lymph-node staging accuracy in prostate cancer, suggesting better treatment planning.
PCR analysis of KLK3, FOLH1, and PCA3 expression enables the molecular detection of lymph-node metastasis and, when combined with standard histopathological examination, improves the accuracy and sensitivity of lymph-node staging. It also refines risk stratification for postoperative BCR, particularly by identifying pathologically node-negative patients at increased risk. Molecular lymph-node assessment based on these markers may therefore serve as a useful prognostic tool to guide adjuvant treatment decisions, although larger prospective studies are needed to validate these findings.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: